• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Adv Wound Care (New Rochelle) . Cutaneous manifestations of COVID-19: A systematic review

tetano

Editor, Senior Moderator
Adv Wound Care (New Rochelle)


. 2020 Oct 9.
doi: 10.1089/wound.2020.1309. Online ahead of print.
Cutaneous manifestations of COVID-19: A systematic review


Harjas Singh[SUP] 1 [/SUP], Harleen Kaur[SUP] 2 [/SUP], Kanhaiya Singh[SUP] 3 [/SUP], Chandan K Sen[SUP] 4 [/SUP]



Affiliations

Abstract

Objective: Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently a pandemic. Although pulmonary health has been the primary focus of studies during the early days of COVID-19, development of a comprehensive understanding of this emergent disease requires knowledge of all possible disease manifestations in affected patients. This PRISMA-compliant review focuses on cutaneous manifestations reported in COVID-19 patients.
Approach: Literature review was conducted using the PubMed database to examine various cutaneous manifestations related to the SARS-CoV-2 infection. Published articles (n=56) related to search criteria from the onset of the COVID-19 pandemic to June 30, 2020 were included. The primary literature articles included in this paper were mainly from France, Spain, Italy, and the UK.
Results: Unique to many other symptoms of COVID-19, its cutaneous manifestations have been found in people of all age groups including children. The cutaneous manifestations of COVID-19 are varied and include maculopapular, chilblain-like, urticarial, vesicular, livedoid, and petechial lesions. In addition, rashes are common in multisystem inflammatory syndrome in children (MIS-C), a new and serious health condition that shares symptoms with Kawasaki disease and is likely related to COVID-19. In addition, personal protective equipment (PPE)-related skin wounds are of serious concern since broken cutaneous barriers can create an opening for potential COVID-19 infections. Innovation and Conclusion: As this virus continues to spread silently, mainly through asymptomatic carriers, an accurate and rapid identification of these cutaneous manifestations may be vital to early diagnosis and lead to possible better prognosis in COVID-19 patients. This systematic review and photo atlas provide a detailed analysis of the skin pathologies related to COVID-19. Study of these cutaneous manifestations, their pathogenesis, as well their significance in human health will help define COVID-19 in its entirety which is a prerequisite to its effective management.
 
Back
Top Bottom